Introduction: An important consideration in treating acute mania is the pro
mptness with which a chosen therapy can bring symptom amelioration. This ar
ticle reviews the available published data from controlled, blinded studies
regarding the latency of responses to antipsychotics in patients with acut
e mania.
Methods: Articles for this review wet e obtained fi om a search of the Medl
ine database (1966-1999), using the following keywords and phrases: antipsy
chotic. atypical, bipolar disorder, mania, neuroleptic, typical. The biblio
graphic sections of articles gleaned from this search were used to direct F
urther inquiries.
Results: Although information regarding the onset of action of antipsychoti
cs is limited, we discovered data for four typical and three atypical antip
sychotics. Drugs with the fastest onsets include haloperidol, risperidone,
and olanzapine, with onsets appearing in 2-6 days. Chlorpromazine and thiot
hixene were at the slowest end of the continuum, with onsets of 2 weeks or
longer. Data regarding pimozide are mixed, with some studies showing an ons
et equivalent to that of the 'fast' compounds and others showing one simila
r to that of the 'slow' compounds.
Conclusions: Choice of therapy should consider nor only efficacy and safety
, but also onset speed. Atypical antipsychotics appear to offer safer, fast
er, and more effective therapies.